Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWAP-4: Switching from Ticagrelor to Clopidogrel in CAD
NCT02287909Phase 4Completed
- Sponsor
- University of Florida
- Start
- Dec 2014
- Primary completion
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clopidogrel in coronary artery disease (CAD) (4 arms), sponsored by University of Florida. Primary endpoint: Platelet Reactivity Unit at 48 hours. Started Dec 2014; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02287909.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02287909.